EyePoint Pharmaceuticals, Inc. — Director's Dealing 2009

Jun 29, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2009-06-25

Reporting Person: Freedman Lori (VP Corp Affairs,Gen Coun & Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-06-25	Common Stock	A	31616	—	Acquired	96423	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-06-25	Employee Stock Option (right to buy)	$1.81	A	95000	Acquired	2019-06-25	Common Stock (95000)	Direct

Footnotes

F1: This award was granted in lieu of a cash payment for part of the reporting person's fiscal year 2009 short term incentive compensation.

F2: The option becomes exercisable in four equal annual installments beginning on the first anniversary of the date of grant.